Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study

被引：5
|
作者：
Cruickshank, JM [1 ]
机构：
[1] Oxonian Cardiovasc Consultancy, Long Melford CO10 9DE, Suffolk, England
来源：
LANCET | 2002年 / 359卷 / 9324期
关键词：
D O I：
10.1016/S0140-6736(02)09071-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2200 / 2201
页数：2
相关论文
共 50 条
  • [1] Cardiovascular morbidity and mortality in patients without pre-existing vascular disease in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE)
    Devereux, RB
    Dahlof, B
    Kjeldsen, SE
    Julius, S
    Aurup, P
    Beevers, G
    Edelman, J
    de Faire, U
    Fyhrquist, F
    Harris, K
    Ibsen, H
    Kristiansson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Snappin, S
    Wedel, H
    [J]. CIRCULATION, 2002, 106 (19) : 475 - 476
  • [2] Emerging risk factors in patients with diabetes without cardiovascular disease
    Alaveras, A
    Zisaki, A
    Kouloheri, S
    Kalofoutis, A
    [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 2005, 136 (02) : 154 - 154
  • [3] Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease
    Franco, Oscar H.
    Steyerberg, Ewout W.
    Hu, Frank B.
    Mackenbach, Johan
    Nusselder, Wilma
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (11) : 1145 - 1151
  • [4] Losartan in cardiovascular disease
    de Vogel, Sanne
    Hoorn, Ewout J.
    Papademetriou, Vasilios
    [J]. FUTURE CARDIOLOGY, 2005, 1 (04) : 433 - 446
  • [5] Reduction of cardiovascular events using losartan? - The LIFE study
    Schunkert, H
    [J]. INTERNIST, 2003, 44 (03): : 367 - 370
  • [6] Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
    Lindholm, LH
    Ibsen, H
    Dahlöf, B
    Devereux, RB
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Kristiansson, K
    Lederballe-Pedersen, O
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Aurup, P
    Edelman, J
    Snapinn, S
    [J]. LANCET, 2002, 359 (9311): : 1004 - 1010
  • [7] Predictors of Atherosclerotic Cardiovascular Disease Risk in Subjects With Diabetes With and Without Cardiovascular Disease: The ACCORD Study
    Wong, Nathan D.
    Zhao, Yanglu
    Bertoni, Alain
    Hlavacek, Patrick
    Tarasenko, Lisa
    Masseria, Cristina
    [J]. CIRCULATION, 2017, 136
  • [8] Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
    Tonkin, Andrew
    Hunt, David
    Voysey, Merryn
    Kesaniemi, Antero
    Hamer, Andrew
    Waites, Jonathon
    Mahar, Leo
    Mann, Stewart
    Glasziou, Paul
    Forder, Peta
    Simes, John
    Keech, Anthony C.
    [J]. AMERICAN HEART JOURNAL, 2012, 163 (03) : 508 - 514
  • [9] Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort study
    Dea Haagensen Kofod
    Nicholas Carlson
    Ellen Freese Ballegaard
    Thomas Peter Almdal
    Christian Torp-Pedersen
    Gunnar Gislason
    Jesper Hastrup Svendsen
    Bo Feldt-Rasmussen
    Mads Hornum
    [J]. Cardiovascular Diabetology, 22
  • [10] Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort study
    Kofod, Dea Haagensen
    Carlson, Nicholas
    Ballegaard, Ellen Freese
    Almdal, Thomas Peter
    Torp-Pedersen, Christian
    Gislason, Gunnar
    Svendsen, Jesper Hastrup
    Feldt-Rasmussen, Bo
    Hornum, Mads
    [J]. CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
12345